Evidence map›Paper›PMID 34951471›Full record

ReviewJournal of the Pediatric Infectious Diseases Society2021

Insight Into Host-Microbe Interactions Using Microbial Flow Cytometry Coupled to Next-Generation Sequencing.

Michael A Silverman, Jamal L Green

Abstract readReview
In one paragraph

Review in Journal of the Pediatric Infectious Diseases Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael A SilvermanDepartment of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Jamal L GreenDepartment of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Funding

A Pediatric Microbial Community to Dissect Host-Commensal Interactions in Type 1 DiabetesR21AI146629 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI SILVERMAN, MICHAEL A · 2020 to 2021
$484k
Leveraging humoral immunity to promote commensal microbial protection from T1DR21AI153956 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI SILVERMAN, MICHAEL A · 2020 to 2021
$484k
Juvenile Diabetes Research Foundation 5-CDA-2020-946-S-BNIAID NIH HHS R21 AI146629NIAID NIH HHS R21 AI153956NIH HHS 1R21AI153956-01
6 · The paper itself

Abstract

Antibody-based assays have been a cornerstone of infectious disease diagnostics for over 100 years [1]. These assays rely on the exquisite sensitivity and specificity of humoral response to almost all infections. While next-generation sequencing (NGS) has tremendous potential to improve diagnostics and uncover host-microbial relationships by directly identifying nucleic acids from infectious microbes, challenges and opportunities for new approaches remain. Here, we review a group of cutting-edge techniques that couple antibody responses with flow cytometry of antibody tagged microbes and NGS. These studies are bringing into focus the dynamic relationship between our immune systems and endogenous microbial communities, which are an important source of pathogens. For simplicity, we use the umbrella term mFLOW-Seq (microbial flow cytometry coupled to NGS) to describe these approaches.

Indexed as

Communicable DiseasesMicrobiotaFlow CytometryHigh-Throughput Nucleotide SequencingHost Microbial InteractionsHumansantibodymFLOW-Seqmicrobial flow cytometrymicrobiome

Identifiers

PMID34951471
PMCPMC8703255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.